{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T10:02:00Z","timestamp":1789466520844,"version":"build-2803163510"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003621","name":"MSIP","doi-asserted-by":"publisher","award":["NRF-2017M3A9F5030273"],"award-info":[{"award-number":["NRF-2017M3A9F5030273"]}],"id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003621","name":"MSIP","doi-asserted-by":"publisher","award":["NRF-2017M3A9B3063640"],"award-info":[{"award-number":["NRF-2017M3A9B3063640"]}],"id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.ijbiomac.2018.03.059","type":"journal-article","created":{"date-parts":[[2018,3,18]],"date-time":"2018-03-18T11:50:01Z","timestamp":1521373801000},"page":"341-348","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Attenuation of inflammation and cartilage degradation by sulfasalazine-containing hyaluronic acid on osteoarthritis rat model"],"prefix":"10.1016","volume":"114","author":[{"given":"Sung Eun","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Yong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyu-Sik","family":"Shim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunghee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoengwoo","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Hoon","family":"Bae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hak-Jun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyeongsoon","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hae-Ryong","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ijbiomac.2018.03.059_bb0005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.berh.2005.09.007","article-title":"Osteoarthritis: epidemiology","volume":"20","author":"Arden","year":"2006","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2018.03.059_bb0010","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1002\/jcp.21258","article-title":"Osteoarthritis","volume":"213","author":"Goldring","year":"2007","journal-title":"J. Cell. Physiol."},{"issue":"11","key":"10.1016\/j.ijbiomac.2018.03.059_bb0015","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/j.joca.2009.04.009","article-title":"OA clinical trials: current targets and trials for OA. Choosing molecular targets: what have we learned and where we are headed?","volume":"17","author":"Hellio Le Graverand-Gastineau","year":"2009","journal-title":"Osteoarthr. Cartil."},{"issue":"9","key":"10.1016\/j.ijbiomac.2018.03.059_bb0020","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1007\/s10067-014-2692-1","article-title":"Impact and therapy of osteoarthritis: the Arthritis Care OA Nation 2012 survey","volume":"34","author":"Conaghan","year":"2015","journal-title":"Clin. Rheumatol."},{"issue":"12","key":"10.1016\/j.ijbiomac.2018.03.059_bb0025","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.1002\/art.10631","article-title":"Timing of total joint replacement affects clinical outcomes among patients with osteoarthritis of the hip or knee","volume":"46","author":"Fortin","year":"2002","journal-title":"Arthritis Rheum."},{"issue":"9783","key":"10.1016\/j.ijbiomac.2018.03.059_bb0030","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/S0140-6736(11)60243-2","article-title":"Osteoarthritis: an update with relevance for clinical practice","volume":"377","author":"Bijlsma","year":"2011","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ijbiomac.2018.03.059_bb0035","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/0049-0172(79)90006-4","article-title":"Epidemiologic and etiologic approach of osteoarthritis","volume":"8","author":"Peyron","year":"1979","journal-title":"Semin. Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.ijbiomac.2018.03.059_bb0040","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1002\/1529-0131(200106)44:6<1237::AID-ART214>3.0.CO;2-F","article-title":"Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets","volume":"44","author":"Pelletier","year":"2001","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.ijbiomac.2018.03.059_bb0045","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.joca.2007.12.013","article-title":"OARSI recommendations for the management of hip and knee osteoarthritis, part II: OARSI evidence-based, expert consensus guidelines","volume":"16","author":"Zhang","year":"2008","journal-title":"Osteoarthr. Cartil."},{"issue":"2","key":"10.1016\/j.ijbiomac.2018.03.059_bb0050","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s10735-012-9457-4","article-title":"Preliminary histopathological study of intra-articular injection of a novel highly cross-linked hyaluronic acid in a rabbit model of knee osteoarthritis","volume":"44","author":"Iannitti","year":"2013","journal-title":"J. Mol. Histol."},{"key":"10.1016\/j.ijbiomac.2018.03.059_bb0055","doi-asserted-by":"crossref","first-page":"406731","DOI":"10.1155\/2014\/406731","article-title":"Topical delivery of aceclofenac: challenges and promises of novel drug delivery systems","volume":"2014","author":"Raza","year":"2014","journal-title":"Biomed. Res. Int."},{"issue":"2","key":"10.1016\/j.ijbiomac.2018.03.059_bb0060","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.addr.2006.01.018","article-title":"Intraarticular drug delivery in osteoarthritis","volume":"58","author":"Gerwin","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"3","key":"10.1016\/j.ijbiomac.2018.03.059_bb0065","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/clpt.1986.45","article-title":"Pharmacokinetics and pharmacodynamics of glucocorticoid suspensions after intra-articular administration","volume":"39","author":"Derendorf","year":"1986","journal-title":"Clin. Pharmacol. Ther."},{"issue":"11","key":"10.1016\/j.ijbiomac.2018.03.059_bb0070","doi-asserted-by":"crossref","first-page":"4622","DOI":"10.1002\/jps.21346","article-title":"Intra-articular depot formulation principles: role in the management of postoperative pain and arthritic disorders","volume":"97","author":"Larsen","year":"2008","journal-title":"J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.ijbiomac.2018.03.059_bb0075","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/ar623","article-title":"Intra-articular hyaluronan (hyaluronic acid) and hylans for the treatment of osteoarthritis: mechanisms of action","volume":"5","author":"Moreland","year":"2003","journal-title":"Arthritis Res. Ther."},{"issue":"6","key":"10.1016\/j.ijbiomac.2018.03.059_bb0080","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/1529-0131(200006)43:6<1192::AID-ANR2>3.0.CO;2-L","article-title":"Intraarticular injection of hyaluronan as treatment for knee osteoarthritis: what is the evidence?","volume":"43","author":"Brandt","year":"2000","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.ijbiomac.2018.03.059_bb0085","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.gene.2013.05.069","article-title":"A current review of molecular mechanisms regarding osteoarthritis and pain","volume":"527","author":"Lee","year":"2013","journal-title":"Gene"},{"issue":"6","key":"10.1016\/j.ijbiomac.2018.03.059_bb0090","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1002\/art.34453","article-title":"Osteoarthritis: a disease of the joint as an organ","volume":"64","author":"Loeser","year":"2012","journal-title":"Arthritis Rheum."},{"issue":"Suppl. 1","key":"10.1016\/j.ijbiomac.2018.03.059_bb0095","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/oxfordjournals.rheumatology.a031492","article-title":"Current treatment paradigms in rheumatoid arthritis","volume":"39","author":"Fries","year":"2000","journal-title":"Rheumatology"},{"issue":"10","key":"10.1016\/j.ijbiomac.2018.03.059_bb0100","doi-asserted-by":"crossref","first-page":"768","DOI":"10.7326\/0003-4819-131-10-199911160-00009","article-title":"Combination therapy with multiple disease-modifying antirheumatic drugs in rheumatoid arthritis: a preventive strategy","volume":"131","author":"Pincus","year":"1999","journal-title":"Ann. Intern. Med."},{"issue":"1","key":"10.1016\/j.ijbiomac.2018.03.059_bb0105","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2165\/00003495-199550010-00009","article-title":"Sulfasalazine. A review of its pharmacological properties and therapeutic efficacy in the treatment of rheumatoid arthritis","volume":"50","author":"Rains","year":"1995","journal-title":"Drugs"},{"issue":"4","key":"10.1016\/j.ijbiomac.2018.03.059_bb0110","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/MCG.0b013e3181cadbe1","article-title":"Pancreatitis in inflammatory bowel diseases","volume":"44","author":"Pitchumoni","year":"2010","journal-title":"J. Clin. Gastroenterol."},{"issue":"Suppl. 2","key":"10.1016\/j.ijbiomac.2018.03.059_bb0115","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/rheumatology\/XXXIV.suppl_2.30","article-title":"The antirheumatic agents sulphasalazine and methotrexate share an anti-inflammatory mechanism","volume":"34","author":"Cronstein","year":"1995","journal-title":"Br. J. Rheumatol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2018.03.059_bb0120","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1053\/j.gastro.2004.10.003","article-title":"Inhibition of inhibitor of kappaB kinases stimulates hepatic stellate cell apoptosis and accelerated recovery from rat liver fibrosis","volume":"128","author":"Oakley","year":"2005","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.ijbiomac.2018.03.059_bb0125","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0006-291X(03)00788-5","article-title":"An absolute role of the PKC-dependent NF-kappaB activation for induction of MMP-9 in hepatocellular carcinoma cells","volume":"305","author":"Hah","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.ijbiomac.2018.03.059_bb0130","first-page":"550","article-title":"Salazosulfapyridine suppresses chondrocyte mediated degradation induced by interleukin 1beta","volume":"24","author":"Nose","year":"1997","journal-title":"J. Rheumatol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2018.03.059_bb0135","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1172\/JCI992","article-title":"Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B","volume":"101","author":"Wahl","year":"1998","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.ijbiomac.2018.03.059_bb0140","first-page":"653","article-title":"Effects of sulfasalazine and its metabolites on steady state messenger RNA concentrations for inflammatory cytokines, matrix metalloproteinases, and tissue inhibitors of metalloproteinase in rheumatoid synovial fibroblasts","volume":"27","author":"Minghetti","year":"2000","journal-title":"J. Rheumatol."},{"issue":"10","key":"10.1016\/j.ijbiomac.2018.03.059_bb0145","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1093\/rheumatology\/kep236","article-title":"Sulfasalazine blocks the release of proteoglycan and collagen from cytokine stimulated cartilage and down-regulates metalloproteinases","volume":"48","author":"Lakey","year":"2009","journal-title":"Rheumatology"},{"issue":"2","key":"10.1016\/j.ijbiomac.2018.03.059_bb0150","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1136\/gut.34.2.252","article-title":"Inhibition of leucocyte adhesion molecule upregulation by tumor necrosis factor alpha: a novel mechanism of action of sulphasalazine","volume":"34","author":"Greenfield","year":"1993","journal-title":"Gut"},{"issue":"Suppl. 2","key":"10.1016\/j.ijbiomac.2018.03.059_bb0155","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/rheumatology\/XXXIV.suppl_2.2","article-title":"The history of the use of sulphasalazine in rheumatology","volume":"34","author":"Amos","year":"1995","journal-title":"Br. J. Rheumatol."},{"key":"10.1016\/j.ijbiomac.2018.03.059_bb0160","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.colsurfb.2016.07.050","article-title":"Ibuprofen-loaded porous microspheres suppressed the progression of monosodium iodoacetate-induced osteoarthritis in a rat model","volume":"147","author":"Park","year":"2016","journal-title":"Colloids Surf. B: Biointerfaces"},{"issue":"4","key":"10.1016\/j.ijbiomac.2018.03.059_bb0165","first-page":"363","article-title":"Animal models of osteoarthritis","volume":"1","author":"Bendele","year":"2001","journal-title":"J. Musculoskelet. Neuronal Interact."},{"issue":"1","key":"10.1016\/j.ijbiomac.2018.03.059_bb0170","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.joca.2005.07.014","article-title":"Osteoarthritis cartilage histopathology: grading and staging","volume":"14","author":"Pritzker","year":"2006","journal-title":"Osteoarthr. Cartil."},{"issue":"1","key":"10.1016\/j.ijbiomac.2018.03.059_bb0175","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3109\/03009749009092617","article-title":"Salicylazosulfapyridine (Salazopyrin) effect on endotoxin-induced production of interleukin-1-like factor from human monocytes in vitro","volume":"19","author":"Remvig","year":"1990","journal-title":"Scand. J. Rheumatol."},{"issue":"10","key":"10.1016\/j.ijbiomac.2018.03.059_bb0180","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0024-3205(00)00708-6","article-title":"The in vitro immunomodulatory effects of sulfasalazine on human polymorphonuclear leukocytes, mononuclear cells, and cultured glomerular mesangial cells","volume":"67","author":"Tsai","year":"2000","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.ijbiomac.2018.03.059_bb0185","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1210\/en.2004-0809","article-title":"Sulfasalazine and BAY 11-7082 interfere with the nuclear factor-kappa B and I kappa B kinase pathway to regulate the release of proinflammatory cytokines from human adipose tissue and skeletal muscle in vitro","volume":"146","author":"Lappas","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.ijbiomac.2018.03.059_bb0190","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13018-016-0346-5","article-title":"Animal models of osteoarthritis: classification, update, and measurement of outcomes","volume":"11","author":"Kuyinu","year":"2016","journal-title":"J. Orthop. Surg. Res."},{"issue":"2","key":"10.1016\/j.ijbiomac.2018.03.059_bb0195","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.gene.2013.11.091","article-title":"Pain assessment in animal models of osteoarthritis","volume":"537","author":"Piel","year":"2014","journal-title":"Gene"},{"issue":"9","key":"10.1016\/j.ijbiomac.2018.03.059_bb0200","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1002\/art.1780400917","article-title":"Mono-iodoacetate-induced experimental osteoarthritis: a dose-response study of loss of mobility, morphology, and biochemistry","volume":"40","author":"Guingamp","year":"1997","journal-title":"Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.ijbiomac.2018.03.059_bb0205","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/art.27290","article-title":"The role of synovial macrophages and macrophage-produced mediators in driving inflammatory and destructive responses in osteoarthritis","volume":"62","author":"Bondeson","year":"2010","journal-title":"Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.ijbiomac.2018.03.059_bb0210","doi-asserted-by":"crossref","first-page":"R187","DOI":"10.1186\/ar2099","article-title":"The role of synovial macrophages and macrophage-produced cytokines in driving aggrecanases, matrix metalloproteinases, and other destructive and inflammatory responses in osteoarthritis","volume":"8","author":"Bondeson","year":"2006","journal-title":"Arthritis Res. Ther."},{"issue":"3","key":"10.1016\/j.ijbiomac.2018.03.059_bb0215","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1006\/clim.2002.5283","article-title":"Phenotypic characterization of inflammatory cells from osteoarthritic synovium and synovial fluids","volume":"105","author":"Haynes","year":"2002","journal-title":"Clin. Immunol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2018.03.059_bb0220","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/1529-0131(200004)43:4<801::AID-ANR10>3.0.CO;2-4","article-title":"Interleukin-1 induction of collagenase 3 (matrix metalloproteinase 13) gene expression in chondrocytes requires p38, c-Jun N-terminal kinase, and nuclear factor kappaB: differential regulation of collagenase 1 and collagenase 3","volume":"43","author":"Mengshol","year":"2000","journal-title":"Arthritis Rheum."},{"issue":"9","key":"10.1016\/j.ijbiomac.2018.03.059_bb0225","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1172\/JCI118636","article-title":"The new collagenase, collagenase-3, is expressed and synthesized by human chondrocytes but not by synoviocytes. A role in osteoarthritis","volume":"97","author":"Reboul","year":"1996","journal-title":"J. Clin. Invest."},{"issue":"8","key":"10.1016\/j.ijbiomac.2018.03.059_bb0230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0134856","article-title":"Anti-osteoarthritic effects of the Litsea japonica fruit in a rat model of osteoarthritis induced by monosodium iodoacetate","volume":"10","author":"Jeong","year":"2015","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.ijbiomac.2018.03.059_bb0235","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1089\/rej.2013.1439","article-title":"Treatment with SiMiaoFang, an anti-arthritis Chinese herbal formula, inhibits cartilage matrix degradation in osteoarthritis rat model","volume":"16","author":"Xu","year":"2013","journal-title":"Rejuvenation Res."},{"issue":"11","key":"10.1016\/j.ijbiomac.2018.03.059_bb0240","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1046\/j.1365-2036.1999.00633.x","article-title":"The effect of an inhibitor of matrix metalloproteinases on colonic inflammation in a trinitrobenzenesulphonic acid rat model of inflammatory bowel disease","volume":"13","author":"Sykes","year":"1999","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"7","key":"10.1016\/j.ijbiomac.2018.03.059_bb0245","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s000110050597","article-title":"An investigation into the effect and mechanisms of action of nicotine in inflammatory bowel disease","volume":"49","author":"Sykes","year":"2000","journal-title":"Inflamm. Res."},{"issue":"8","key":"10.1016\/j.ijbiomac.2018.03.059_bb0250","first-page":"669","article-title":"Knee osteoarthritis: should your patient opt for hyaluronic acid injection?","volume":"55","author":"Medina","year":"2006","journal-title":"J. Fam. Pract."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813018301764?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813018301764?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T23:43:40Z","timestamp":1565307820000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813018301764"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":50,"alternative-id":["S0141813018301764"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2018.03.059","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Attenuation of inflammation and cartilage degradation by sulfasalazine-containing hyaluronic acid on osteoarthritis rat model","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2018.03.059","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}